Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 15 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Head and Neck Neoplasms 4 Lung Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Neuroblastoma 2 Adenocarcinoma 2 Wilms Tumor 1 Stomatitis 1 Squamous Cell Cancer of Head and Neck (SCCHN) 1 Skin Neoplasms 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Radiation Injuries 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Pelvic Neoplasms 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1

Interventions

Surveys and Questionnaires 114 Exercise 103 Blood Specimen Collection 99 Radiotherapy 67 Gemcitabine 64 Bevacizumab 57 Standard of Care 56 Cisplatin 55 Cyclophosphamide 51 Capecitabine 50 Carboplatin 49 Docetaxel 47 pembrolizumab 46 Dexamethasone 46 Paclitaxel 45 Interviews as Topic 43 Oxaliplatin 40 Magnetic Resonance Spectroscopy 39 Fluorouracil 37 Methods 36 Irinotecan 36 Therapeutics 33 Drug Therapy 33 Radiosurgery 31 Nivolumab 30 Erlotinib Hydrochloride 27 Educational Status 26 Everolimus 24 Leucovorin 23 Control Groups 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Radiotherapy, Image-Guided × Clear all

NCT02272400 2021-01-14

PBI

NYU Langone Health

Phase NA Completed

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡